5,6-Diarylanthranilo-1,3-dinitriles as a new class of antihyperglycemic agents

Bioorg Med Chem Lett. 2009 Apr 15;19(8):2158-61. doi: 10.1016/j.bmcl.2009.02.118. Epub 2009 Mar 4.

Abstract

Various functionalized mono- and diarylanthranilo-1,3-dinitriles were synthesized and evaluated for their in vitro antihyperglycemic activity against the PTP-1B, glucose-6-phosphatase, glycogen phosphorylase and alpha-glucosidase enzymes. Among various screened compounds, 5,6-diaryl substituted anthranilo-1,3-dinitriles 3a, 3b, and 3d showed good inhibitory activity against PTP-1B with IC(50) values of 58-72 microM. Three of the test compounds showed significant (25-37%) lowering of plasma glucose level at 24h in sucrose-challenged streptozotocin-induced diabetic Sprague-Dawley rat model.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy
  • Hypoglycemic Agents / chemical synthesis*
  • Hypoglycemic Agents / classification*
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Hypoglycemic Agents